Unpacking the Final Trades: GDX, Pfizer, GlobalFoundries, and Bristol Myers Squibb Under the Microscope
Pharma's Unseen Shift: Citi's Meacham Reveals Deep-Rooted U.S. Investment Promises Already Underway
Aerospace Ascendant: Easing Restrictions Propel This Stock to New Heights, Says The Club